![Jennifer Locke](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Jennifer Locke currently works at ClearB Therapeutics, Inc., as Chief Operating & Business Officer and Adiso Therapeutics, Inc., as Chief Operating & Business Officer from 2022.
Aktive Positionen von Jennifer Locke
Unternehmen | Position | Beginn |
---|---|---|
ClearB Therapeutics, Inc.
![]() ClearB Therapeutics, Inc. BiotechnologyHealth Technology ClearB Therapeutics, Inc. is a company that focuses on therapeutics. The company is based in Concord, MA. The company was co-founded in 2017 by Morningside Ventures in collaboration with Professor Stephen Locarnini and the Victoria Infectious Diseases Reference Laboratory. Aileen Rubio has been the CEO of the company since 2018. | Geschäftsführer | - |
Adiso Therapeutics, Inc.
![]() Adiso Therapeutics, Inc. BiotechnologyHealth Technology Adiso Therapeutics, Inc. creates medicines to treat inflammatory diseases with the goal of improving the lives of patients and their families. Adiso Therapeutics is based in Concord, MA. The company believes that current therapeutic approaches are often inadequate and can pose significant safety concerns for patients. Scott T. Megaffin has been the CEO of the company since 2022. | Geschäftsführer | 01.01.2022 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
ClearB Therapeutics, Inc.
![]() ClearB Therapeutics, Inc. BiotechnologyHealth Technology ClearB Therapeutics, Inc. is a company that focuses on therapeutics. The company is based in Concord, MA. The company was co-founded in 2017 by Morningside Ventures in collaboration with Professor Stephen Locarnini and the Victoria Infectious Diseases Reference Laboratory. Aileen Rubio has been the CEO of the company since 2018. | Health Technology |
Adiso Therapeutics, Inc.
![]() Adiso Therapeutics, Inc. BiotechnologyHealth Technology Adiso Therapeutics, Inc. creates medicines to treat inflammatory diseases with the goal of improving the lives of patients and their families. Adiso Therapeutics is based in Concord, MA. The company believes that current therapeutic approaches are often inadequate and can pose significant safety concerns for patients. Scott T. Megaffin has been the CEO of the company since 2022. | Health Technology |